Nisa Investment Advisors
COGT icon

Nisa Investment Advisors’s Cogent Biosciences COGT Stock Holding History

Nisa Investment Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Buy
5,815
+3,960
+213% +$146K ﹤0.01% 1179
2025
Q4 		$65.9K Buy
1,855
+488
+36% +$13.7K ﹤0.01% 1556
2025
Q3 		$19.6K Buy
1,367
+10
+0.7% +$118 ﹤0.01% 2003
2025
Q2 		$9.74K Buy
1,357
+100
+8% +$554 ﹤0.01% 2279
2025
Q1 		$7.53K Sell
1,257
-106
-8% -$831 ﹤0.01% 2167
2024
Q4 		$10.6K Buy
1,363
+100
+8% +$997 ﹤0.01% 2120
2024
Q3 		$13.6K Buy
1,263
+53
+4% +$516 ﹤0.01% 2032
2024
Q2 		$10.2K Buy
1,210
+115
+11% +$872 ﹤0.01% 2147
2024
Q1 		$7.36K Buy
1,095
+40
+4% +$247 ﹤0.01% 2082
2023
Q4 		$6.2K Sell
1,055
-770
-42% -$5.9K ﹤0.01% 2103
2023
Q3 		$17.8K Buy
1,825
+771
+73% +$9.14K ﹤0.01% 2054
2023
Q2 		$12.5K Buy
1,054
+1,046
+13,075% +$12K ﹤0.01% 2220
2023
Q1 		$0 Hold
8
– – ﹤0.01% 2560
2022
Q4 		$0 Sell
8
-42
-84% -$520 ﹤0.01% 2601
2022
Q3 		$1K Buy
+50
New +$685 ﹤0.01% 2402

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Nisa Investment Advisors's COGT Position: Q1 2026 in Review

Nisa Investment Advisors increased its Cogent Biosciences (COGT) stake by 213% in Q1 2026, buying an estimated $146K and bringing the position to 5,815 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Nisa Investment Advisors first reported a position in COGT in Q3 2022 and has held it in 15 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Nisa Investment Advisors held 5,815 shares of Cogent Biosciences worth $224K as of Q1 2026.
  • Nisa Investment Advisors bought 3,960 Cogent Biosciences shares in Q1 2026, an estimated $146K.
  • Cogent Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1179 holding.
  • Nisa Investment Advisors first reported a position in Cogent Biosciences in Q3 2022 and has held it in 15 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.